Showing results (141-150 of 247) with videos related to

Sort By:
Pageof 25
Emerging Infectious Diseases|January 22, 2020
Surge in Anaplasmosis Cases in Maine, USA, 2013-2017Susan P Elias, Jessica Bonthius, Sara Robinson, et al.
Journal of Vector Ecology : Journal of the Society for Vector Ecology|June 4, 2011
Density of Ixodes scapularis ticks on Monhegan Island after complete deer removal: a question of avian importation?Susan P Elias, Robert P Smith, Sara R Morris, et al.
FEMS Immunology and Medical Microbiology|April 16, 1998
Culture supernatant of Shiga toxin-producing Escherichia coli strains provoke fluid accumulation in rabbit ileal loopsA J Ferreira, W P Elias, J S Pelayo, et al.
General and Comparative Endocrinology|October 6, 2000
Evolution of the thyroid hormone-binding protein, transthyretinD M Power, N P Elias, S J Richardson, et al.
Infection and Immunity|September 25, 1999
Involvement of the enteroaggregative Escherichia coli plasmid-encoded toxin in causing human intestinal damageI R Henderson, S Hicks, F Navarro-Garcia, et al.
Frontiers in Physiology|October 19, 2018
The Individual and Combined Effects of Multiple Factors on the Risk of Soft Tissue Non-contact Injuries in Elite Team Sport AthletesAlireza Esmaeili, William G Hopkins, Andrew M Stewart, et al.
Infection and Immunity|November 12, 2014
Late establishment of the attaching and effacing lesion caused by atypical enteropathogenic Escherichia coli depends on protein expression regulated by PerVanessa Bueris, Jazmín Huerta-Cantillo, Fernando Navarro-Garcia, et al.
Applied and Environmental Microbiology|October 30, 2012
Autotransporter protein-encoding genes of diarrheagenic Escherichia coli are found in both typical and atypical enteropathogenic E. coli strainsAfonso G Abreu, Vanessa Bueris, Tatiane M Porangaba, et al.
The Journal of Investigative Dermatology|February 1, 1996
Localization of the Darier disease gene to a 2-cM portion of 12q23-24.1P Wakem, S Ikeda, A Haake, et al.
Arthritis and Rheumatism|March 1, 1995
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic SclerosisB White, E A Bauer, L A Goldsmith, et al.
Pageof 25